Welcome to our dedicated page for Ayr Wellness news (Ticker: AYRWF), a resource for investors and traders seeking the latest updates and insights on Ayr Wellness stock.
AYR Wellness Inc. (AYRWF) generates frequent news due to its role as a vertically integrated U.S. multi-state cannabis operator and its ongoing capital structure restructuring. Company news releases highlight both operational milestones in the cannabis business and significant developments in its financial and legal processes.
On the operational side, AYR has issued news about the opening of its first indoor cultivation facility in Florida and the launch of Kynd brand flower from that site. These updates describe expanded cultivation capacity, a curated library of cannabis genetics, and the availability of new cultivars for registered medical marijuana patients at AYR Wellness dispensaries across Florida.
A substantial portion of AYR’s recent news flow focuses on its restructuring activities. The company has announced a Restructuring Support Agreement with an ad hoc committee of consenting senior noteholders, the commencement of Article 9 foreclosure sale proceedings for certain collateral assets and equity interests of specified subsidiaries, and the result of a public auction in which senior noteholders submitted the successful credit bid. AYR has also reported the execution of a Master Purchase Agreement to transfer core assets to a newly formed acquisition vehicle owned by certain senior noteholders, subject to regulatory approvals.
Additional news items cover the execution of a senior secured Bridge Credit Agreement, extensions of a Limited Waiver Agreement with senior noteholders, and the initiation of proceedings under the Companies’ Creditors Arrangement Act in British Columbia to facilitate a court-supervised wind-down of the existing corporate parent. Leadership updates, including changes in interim executive roles, are also disclosed through news releases.
Investors and observers can use this news page to follow AYR’s operational announcements in its cannabis markets alongside detailed updates on the restructuring process, Article 9 sale, bridge financing, waiver agreements, and CCAA proceedings.
AYR Wellness (OTCQX: AYRWF) has secured an extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 18, 2025. The waiver addresses defaults related to delayed Q1 2025 financial filings and certain payment defaults on outstanding debt.
The temporary waiver prevents noteholders from exercising default-related rights while the company continues negotiations with senior lenders and explores strategic options to strengthen its capital structure. AYR continues to operate normally and evaluate growth opportunities while working with stakeholders to address its financial obligations.
AYR Wellness (OTCQX: AYRWF) has received a Notification of Disposition of Collateral from Anthony J. DePaul regarding potential reclamation and sale of its interest in PA Natural Medicine LLC, which operates three medical cannabis dispensaries in Pennsylvania. The notice cites alleged defaults under the Pledge Agreement.
Additionally, the company has secured a Second Amendment to its Limited Waiver Agreement with senior noteholders, extending the temporary waiver period to July 11, 2025. This extension relates to defaults from delayed Q1 2025 financial filings and certain payment defaults, providing AYR additional time for negotiations with senior lenders and exploration of capital structure alternatives.
AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, announced it has missed its June 30, 2025 interest payment on its outstanding senior notes. If the payment is not made by July 30, 2025, it will trigger an event of default.
The company's Interim CEO Scott Davido stated this is a strategic step in their ongoing debt restructuring efforts. AYR is currently in discussions with majority noteholders regarding capital structure alternatives as part of a broader strategic review announced on May 30, 2025. The company maintains that the missed interest payment is not expected to impact its operational capabilities.
AYR Wellness (OTCQX: AYRWF), a vertically integrated U.S. multi-state cannabis operator, announced delays in filing its Q1 2025 interim financial statements and related documents. The delay is attributed to ongoing negotiations with creditors and assessment of debt obligation classifications with senior lenders.
The company is currently under a failure-to-file cease-trade order (FFCTO) issued by the Ontario Securities Commission, which prohibits trading of AYR's securities in Canadian jurisdictions and has resulted in a trading suspension on the Canadian Securities Exchange. AYR is conducting a broader strategic review to address upcoming payment obligations and support its long-term strategic plan.
AYR Wellness (CSE: AYR.A, OTCQX: AYRWF) announced significant leadership changes, with Steven M. Cohen stepping down as Interim Chief Executive Officer effective April 04, 2025. The board has appointed Scott Davido as the new Interim CEO.
Cohen, who served as Interim CEO since September 18, 2024, will remain as an advisor to support the transition. Davido joins from Ankura Consulting Group, where he served as senior managing director. His extensive experience includes previous roles as Interim CEO of DCL , CEO of Advantage Rent a Car, and CEO of Experience.com, along with senior executive positions at Calpine and NRG Energy.
Board Chairman Louis Karger acknowledged Cohen's contributions in initiating organizational evolution and welcomed Davido's appointment, citing his track record in positioning companies for sustained success and executing strategic initiatives.
FAQ
What is the current stock price of Ayr Wellness (AYRWF)?
What is the market cap of Ayr Wellness (AYRWF)?
